Diagnostic problems of rare diseases - amyloidosis. A case report
Open Access
- 1 February 2024
- journal article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 56, 37-53
Abstract
The presented case study focuses on the complexities and challenges in diagnosingone of the forms of amyloidosis, where abnormal protein (amyloid) deposits in variousorgans and tissues lead to affection of many organs, especially the heart, kidneys, liver,spleen, and occasionally the central nervous system. Its aetiology remains largely unknown,making diagnosis and treatment particularly challenging.This report details the case of an 88-year-old patient, disabled for months (with amodified Rankin Scale score of 4), who presented to the Neurology Department with suddenright limb paresis and speech disorders. Initial assessments indicated suggested ischemicstroke, and patients received thrombolysis. Further laboratory tests and imaging, includingserum protein electrophoresis and computer tomograph (CT) scans, suggested transthyretinamyloidosis (ATTR), which was later confirmed through genetic testing.This case underscores the rapid, multi-organ progression of amyloidosis and itsdevastating impact, highlighting the necessity for early diagnosis and a multidisciplinarytreatment approach.Despite ongoing research, the pathogenesis of amyloidosis remains elusive, andcurrent treatment options are primarily symptomatic. This study aims to shed light on thediagnostic difficulties and the urgent need for timely intervention in amyloidosis cases.Keywords
This publication has 13 references indexed in Scilit:
- Emerging Therapies for Transthyretin AmyloidosisCurrent Oncology Reports, 2023
- ATTR Epidemiology, Genetics, and Prognostic FactorsMethodist DeBakey Cardiovascular Journal, 2022
- Epidemiology of Heart FailureCirculation Research, 2021
- Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel ReleaseJACC, 2018
- Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart FailureJACC, 2016
- Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin AmyloidosisNeurology and Therapy, 2016
- A Caenorhabditis elegans–based assay recognizes immunoglobulin light chains causing heart amyloidosisBlood, 2014
- Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection FractionJACC: Heart Failure, 2014
- Transthyretin (TTR) Cardiac AmyloidosisCirculation, 2012
- Amyloidosis: Pathogenesis and New Therapeutic OptionsJournal of Clinical Oncology, 2011